{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:19:51Z","timestamp":1783142391990,"version":"3.54.6"},"reference-count":73,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus disease 2019 (COVID\u201019) pandemic has affected millions of individuals worldwide. The global scientific effort to design an effective vaccine against this virus has led to the development of several vaccine candidates. The expedited rollout of these vaccines has created some public distrust regarding the safety of these new vaccines. This review compiles clinical data from reports of diagnosed immune\u2010related neurological events that have occurred after COVID\u201019 vaccine administration with the exception of those secondary to hematological abnormalities. A systematic literature search was performed, using several databases, to identify reports of postvaccination adverse neurological events. The search resulted in 18 studies that met our criteria. These studies included 61 patients who had received COVID\u201019 vaccines and experienced at least 1 neurological adverse effect. The most common neurological event was facial nerve palsy (50% of all events). Other less frequently reported events included the reactivation of herpes zoster, Guillain\u2010Barre syndrome, other demyelinating diseases, and neuropathy. The underlying mechanism was hypothesized to be related to vaccine\u2010induced type 1 interferon production leading to decreased tolerance of the myelin sheath antigens. Other hypotheses include vaccine\u2010induced transient lymphopenia and immune dysregulation. Most of the reported events were time limited and resolved spontaneously. Given the rarity of reported neurological events compared to the total number of vaccines administered, and the similarity in the incidence of events between COVID\u201019 vaccines and other more common vaccines, there is little evidence to support a causal relationship between COVID\u201019 vaccines and adverse neurological events.<\/jats:p>","DOI":"10.1002\/jcph.2017","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:33:49Z","timestamp":1639827229000},"page":"291-303","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neurological Immune\u2010Related Adverse Events After COVID\u201019 Vaccination: A Systematic Review"],"prefix":"10.1002","volume":"62","author":[{"given":"Ameena","family":"Shafiq","sequence":"first","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Salameh","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Laswi","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Mhaimeed","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Mhaimeed","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjis","family":"Mhaimeed","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6283-1596","authenticated-orcid":false,"given":"Pradipta","family":"Paul","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Mushannen","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-2701","authenticated-orcid":false,"given":"Abdallah","family":"Elshafeey","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fares","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Holroyd","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-0038","authenticated-orcid":false,"given":"Dalia","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine Qatar, Qatar Foundation Education City, Al Luqta St. Ar\u2010Rayyan  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"WHO coronavirus (COVID\u201019) dashboard.https:\/\/covid19.who.int. Accessed September 20 2021."},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9010039"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950e2"},{"key":"e_1_2_10_6_1","article-title":"COVID\u201019: UK approves Pfizer and BioNTech vaccine with rollout due to start next week [published online ahead of print December 2, 2020]","author":"Mahase E","journal-title":"BMJ"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107456"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13010109"},{"key":"e_1_2_10_9_1","unstructured":"Moderna COVID\u201019 vaccine EUA letter of authorization.https:\/\/www.fda.gov\/media\/144636\/. Accessed September 20 2021."},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","unstructured":"Moderna's work on our COVID\u201019 vaccine.https:\/\/www.modernatx.com\/modernas\u2010work\u2010potential\u2010vaccine\u2010against\u2010covid\u201019. Accessed September 20 2021.","DOI":"10.1080\/15332985.2021.2007439"},{"key":"e_1_2_10_11_1","doi-asserted-by":"crossref","unstructured":"Serum Institute of India \u2010 chadox1 ncov\u2010 19 corona virus vaccine (Recombinant) \u2010 Covishield.https:\/\/www.seruminstitute.com\/product_covishield.php. Accessed September 20 2021.","DOI":"10.1016\/j.nerep.2021.100006"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020206"},{"key":"e_1_2_10_13_1","unstructured":"EnglPH.Vaccines highly effective against B.1.617.2 variant after 2 doses.GOVUK.https:\/\/www.gov.uk\/government\/news\/vaccines\u2010highly\u2010effective\u2010against\u2010b\u20101\u2010617\u20102\u2010variant\u2010after\u20102\u2010doses. Accessed September 20 2021."},{"key":"e_1_2_10_14_1","unstructured":"AstraZeneca's COVID\u201019 vaccine authorised for emergency supply in the UK.https:\/\/www.astrazeneca.com\/media\u2010centre\/press\u2010releases\/2020\/astrazenecas\u2010covid\u201019\u2010vaccine\u2010authorised\u2010in\u2010uk.html. Accessed September 20 2021."},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00432-3"},{"key":"e_1_2_10_16_1","volume-title":"BBC News","year":"2021"},{"key":"e_1_2_10_17_1","volume-title":"N Y Times","author":"Peltier E","year":"2021"},{"key":"e_1_2_10_18_1","volume-title":"Drugs and Lactation Database (LactMed)","year":"2006"},{"key":"e_1_2_10_19_1","volume-title":"Reuters","year":"2021"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-02386-2"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31866-3"},{"key":"e_1_2_10_22_1","volume-title":"Reuters","year":"2021"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01813-2"},{"key":"e_1_2_10_24_1","volume-title":"NL Times","year":"2021"},{"key":"e_1_2_10_25_1","unstructured":"Janssen Vaccines & Prevention B.V. A Randomized Double\u2010Blind Placebo\u2010Controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26. Cov2. S for the Prevention of Sars\u2010Cov\u20102\u2010Mediated Covid\u201019 in Adults Aged 18 Years and Older.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04505722. Published 2021. Accessed September 19 2021."},{"key":"e_1_2_10_26_1","unstructured":"Statement of the COVID\u201019 subcommittee of the Who Global Advisory Committee on Vaccine Safety (GACVS) on safety signals related to the Johnson & Johnson\/Janssen COVID\u201019 vaccine.https:\/\/www.who.int\/news\/item\/19\u201005\u20102021\u2010statement\u2010gacvs\u2010safety\u2010johnson\u2010johnson\u2010janssen\u2010covid\u201019\u2010vaccine. Accessed September 20 2021."},{"key":"e_1_2_10_27_1","volume-title":"AJMC","year":"2021"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114114"},{"key":"e_1_2_10_30_1","unstructured":"CDC.COVID\u201019 booster shot.https:\/\/www.cdc.gov\/coronavirus\/2019\u2010ncov\/vaccines\/booster\u2010shot.html. Published online November2021. Accessed December 9 2021."},{"key":"e_1_2_10_31_1","article-title":"COVID\u201019 vaccine safety surveillance","author":"Research","year":"2021","journal-title":"Cent Biol Eval Res"},{"key":"e_1_2_10_32_1","unstructured":"Ottawa Hospital Research Institute.http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed December 9 2021."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470988343.app1"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2017-110853"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_10_36_1","doi-asserted-by":"crossref","unstructured":"Diaz\u2010SegarraN EdmondA GilbertC MckayO KloeppingC YonclasP.Painless idiopathic neuralgic amyotrophy after COVID\u201019 vaccination: a case report [published online ahead of print June 9 2021].PM&R.https:\/\/doi.org\/10.1002\/pmrj.12619.","DOI":"10.1002\/pmrj.12619"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab345"},{"issue":"2","key":"e_1_2_10_38_1","first-page":"e13426","article-title":"Neurological complications of COVID\u201019: Guillain\u2010Barre syndrome following Pfizer COVID\u201019 vaccine","volume":"13","author":"Waheed S","year":"2021","journal-title":"Cureus"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27251"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14163"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27255"},{"key":"e_1_2_10_42_1","article-title":"Bell's palsy following COVID\u201019 vaccination [published online ahead of print February 21, 2021]","author":"Colella G","journal-title":"J Neurol"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100217"},{"issue":"3","key":"e_1_2_10_44_1","first-page":"143","article-title":"Peripheral facial nerve palsy following bnt162b2 (COVID\u201019) vaccination","volume":"23","author":"Shemer A","year":"2021","journal-title":"Isr Med Assoc J IMAJ"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2021.03.005"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab069"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011881"},{"key":"e_1_2_10_49_1","article-title":"Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report [published online ahead of print February 1, 2021]","author":"Cao L","journal-title":"Acta Neurol Belg"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.02.011"},{"key":"e_1_2_10_51_1","unstructured":"Possible side effects from vaccines.https:\/\/www.cdc.gov\/vaccines\/vac\u2010gen\/side\u2010effects.htm. Published online August 2021. Accessed September 20 2021."},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.20.2478"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12306"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13417"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511233332102"},{"issue":"8","key":"e_1_2_10_56_1","first-page":"965","article-title":"Real\u2010time analysis of a mass vaccination effort confirms the safety of FDA\u2010authorized mRNA COVID\u201019 vaccines","volume":"2","author":"McMurry R","year":"2021","journal-title":"Med N Y N"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2219"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.01.006"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-027599"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.05.008"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2005.25.174"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31665-3"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.023"},{"issue":"3","key":"e_1_2_10_64_1","first-page":"183","article-title":"Influenza vaccine and autoimmunity","volume":"11","author":"Agmon\u2010Levin N","year":"2009","journal-title":"Isr Med Assoc J IMAJ"},{"key":"e_1_2_10_65_1","volume-title":"StatPearls","author":"Nguyen TP","year":"2021"},{"key":"e_1_2_10_66_1","volume-title":"StatPearls","author":"Anilkumar AC","year":"2021"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.060"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007673"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh722"},{"key":"e_1_2_10_70_1","unstructured":"Vaccine adverse events reporting system (VAERS) help.https:\/\/wonder.cdc.gov\/wonder\/help\/vaers.html. Accessed September 20 2021."},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202010060"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1605501"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-016-0145-4"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13999150424113345"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.2017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcph.2017","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T14:16:21Z","timestamp":1692972981000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1002\/jcph.2017"],"URL":"https:\/\/doi.org\/10.1002\/jcph.2017","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"2021-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}